The FDA plans to mine data submitted by patients on the site PatientsLikeMe.
The FDA, in an attempt to gather post-marketing data directly from the source, is planning to access data submitted on the patient-networking website PatientsLikeMe. The hope is to collect data that patients submit on drug-use experiences, symptoms, and hospitalizations.
The project is currently in its exploratory phase. “We’re hoping we can find information on the impact of adverse events on patients’ day-to-day lives,” said Gerald Dal Pan, director of the Office of Surveillance and Epidemiology at the FDA, in a statement.
Read more on Bloomberg News: http://bloom.bg/1Laqub8
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More